Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data
Crossref DOI link: https://doi.org/10.1007/s13300-014-0083-x
Published Online: 2014-09-23
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kamenov, Zdravko
Text and Data Mining valid from 2014-09-23
Article History
Received: 14 July 2014
First Online: 23 September 2014